Stock OILS NEXTLEAF SOLUTIONS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nextleaf Solutions Ltd.

Equities

OILS

CA65347A1021

Pharmaceuticals

Delayed Canadian Securities Exchange
Other stock markets
 02:47:04 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.15 CAD 0.00% Intraday chart for Nextleaf Solutions Ltd. +11.11% +150.00%
Apr. 20 Nextleaf Solutions Announces New Product Launches Across Core Recreational Cannabis Categories, Alongside National Brand Activations for Acclaimed Legacy-To-Legal Brand Glacial Gold CI
Apr. 02 Nextleaf Solutions Ltd. Announces Launch of Infused Prerolls CI

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023
Capitalization 1 46.47 22.9 30.08 10.75 9.567
Enterprise Value (EV) 1 42.17 22.33 32.41 11.73 9.158
P/E ratio -4.47 x -3.6 x -5.48 x -2.5 x 41 x
Yield - - - - -
Capitalization / Revenue - 33.1 x 8.9 x 2.44 x 1.17 x
EV / Revenue - 32.3 x 9.59 x 2.66 x 1.12 x
EV / EBITDA -7.07 x -5.15 x -8.63 x -7.98 x 7.86 x
EV / FCF -29.9 x -5.09 x -16.3 x -316 x 16.2 x
FCF Yield -3.35% -19.6% -6.15% -0.32% 6.19%
Price to Book 5.19 x 3.15 x 8.78 x 3.57 x 2.31 x
Nbr of stocks (in thousands) 108,062 120,506 125,318 143,330 159,456
Reference price 2 0.4300 0.1900 0.2400 0.0750 0.0600
Announcement Date 1/28/20 1/28/21 1/31/22 1/30/23 1/30/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales 1 0.5234 - 0.6907 3.379 4.41 8.18
EBITDA 1 -1.916 -5.967 -4.338 -3.757 -1.471 1.166
EBIT 1 -2.213 -6.462 -5.405 -4.587 -2.349 0.4781
Operating Margin -422.8% - -782.5% -135.75% -53.27% 5.84%
Earnings before Tax (EBT) 1 -2.204 -8.746 -5.954 -5.385 -3.487 0.2233
Net income 1 -2.204 -8.746 -5.954 -5.385 -3.487 0.2233
Net margin -421.11% - -861.99% -159.37% -79.07% 2.73%
EPS 2 -0.0372 -0.0962 -0.0528 -0.0438 -0.0300 0.001465
Free Cash Flow 1 -2.824 -1.412 -4.384 -1.992 -0.0371 0.5669
FCF margin -539.56% - -634.75% -58.96% -0.84% 6.93%
FCF Conversion (EBITDA) - - - - - 48.64%
FCF Conversion (Net income) - - - - - 253.85%
Dividend per Share - - - - - -
Announcement Date 3/29/19 1/28/20 1/28/21 1/31/22 1/30/23 1/30/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 2.33 0.98 -
Net Cash position 1 0.84 4.3 0.57 - - 0.41
Leverage (Debt/EBITDA) - - - -0.6203 x -0.6694 x -
Free Cash Flow 1 -2.82 -1.41 -4.38 -1.99 -0.04 0.57
ROE (net income / shareholders' equity) -71.4% -132% -74.7% -101% -108% 6.25%
ROA (Net income/ Total Assets) -39.1% -53.7% -34.7% -30.2% -18% 3.81%
Assets 1 5.635 16.29 17.18 17.82 19.41 5.863
Book Value Per Share 2 0.0500 0.0800 0.0600 0.0300 0.0200 0.0300
Cash Flow per Share 2 0.0100 0.0400 0.0100 0.0100 0 0.0100
Capex 1 1.63 1.65 2.61 0.07 0.11 0.02
Capex / Sales 311.92% - 377.39% 1.95% 2.47% 0.29%
Announcement Date 3/29/19 1/28/20 1/28/21 1/31/22 1/30/23 1/30/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
NEXTLEAF SOLUTIONS LTD. Stock Nextleaf Solutions Ltd.
+150.00% 18.04M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.56% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.78% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.74% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.13% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.52% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. OILS Stock
  4. Financials Nextleaf Solutions Ltd.